Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update

Rockwell Medical, Inc. (NASDAQ:RMTI - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling 438,800 shares, a decrease of 13.0% from the January 31st total of 504,200 shares. Currently, 1.6% of the company's shares are sold short. Based on an average daily volume of 414,700 shares, the days-to-cover ratio is currently 1.1 days.

Institutional Trading of Rockwell Medical

Several large investors have recently modified their holdings of RMTI. Two Sigma Securities LLC purchased a new position in Rockwell Medical in the fourth quarter valued at about $33,000. Dimensional Fund Advisors LP purchased a new position in shares of Rockwell Medical during the 4th quarter valued at approximately $146,000. Marshall Wace LLP grew its position in shares of Rockwell Medical by 17.2% during the fourth quarter. Marshall Wace LLP now owns 596,359 shares of the company's stock worth $1,217,000 after buying an additional 87,685 shares in the last quarter. XTX Topco Ltd increased its stake in shares of Rockwell Medical by 58.0% in the fourth quarter. XTX Topco Ltd now owns 44,962 shares of the company's stock worth $92,000 after buying an additional 16,507 shares during the last quarter. Finally, Barclays PLC raised its holdings in Rockwell Medical by 27.5% in the fourth quarter. Barclays PLC now owns 28,854 shares of the company's stock valued at $59,000 after acquiring an additional 6,229 shares in the last quarter. 23.31% of the stock is currently owned by institutional investors and hedge funds.

Rockwell Medical Stock Down 4.9 %

Shares of RMTI traded down $0.08 during mid-day trading on Monday, reaching $1.54. 351,021 shares of the stock traded hands, compared to its average volume of 410,762. The stock has a fifty day simple moving average of $1.96 and a 200 day simple moving average of $2.70. Rockwell Medical has a 12-month low of $1.35 and a 12-month high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The firm has a market cap of $49.77 million, a price-to-earnings ratio of -30.80 and a beta of 1.55.

Remove Ads

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on RMTI. RODMAN&RENSHAW raised shares of Rockwell Medical to a "strong-buy" rating in a research report on Thursday, November 14th. StockNews.com lowered shares of Rockwell Medical from a "buy" rating to a "hold" rating in a report on Friday, December 20th. Rodman & Renshaw began coverage on Rockwell Medical in a report on Thursday, November 14th. They issued a "buy" rating and a $5.00 price target for the company. Finally, HC Wainwright restated a "buy" rating and set a $7.00 price objective on shares of Rockwell Medical in a research note on Monday, December 23rd.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.